Clinical Trials List
Protocol Number114886 TUBERCULOSIS-017
2011-08-01 - 2014-12-31
Phase II
Terminated1
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chong-Jen Yu Division of General Internal Medicine
- 李麗娜 Division of General Internal Medicine
- PAN-CHYR YANG Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
240 participants
-
Global
240 participants
